Comparison of persistent submacular fluid in vitrectomy and scleral buckle surgery for macula-involving retinal detachment.
OBJECTIVE
To compare the frequency of persistent submacular fluid (SMF) and sequential visual outcomes after pars plana vitrectomy (PPV) and scleral buckling (SB) in recent-onset macula-involving rhegmatogenous retinal detachment (RD), and thus to determine the role of persistent SMF on visual outcome with different surgical methods.


METHODS
Observational case series.


METHODS
Sixty-one patients (61 eyes) who underwent successful PPV (16 patients) or SB (45 patients) underwent thorough ophthalmologic examinations including optical coherence tomography at 1 month after surgery, as well as every 3 months until SMF disappeared. The SB group was divided into 2 groups according to the presence (SB-SMF+) or absence (SB-SMF-) of persistent SMF at 1 month after surgery. Preoperative and postoperative best-corrected visual acuities were compared among the different surgical groups and also were analyzed depending on the RD duration (acute, symptom duration < or = 7 days; subacute, symptom duration > 7 and < or = 30 days).


RESULTS
Persistent SMF at 1 month after surgery was more frequent in the SB group (55.6%) than it was in the PPV group (6.25%; P = .006). The SB-SMF+ group showed worse postoperative best-corrected visual acuity than the PPV or SB-SMF- groups at 6 to 12 months after surgery, whereas there were no significant differences in the final visual acuity among the groups. This difference in visual recovery was not observed in patients with subacute RD.


CONCLUSIONS
The similar visual recovery patterns seen in the PPV and SB-SMF- groups suggest that persistent SMF is a more important prognostic factor than surgical method is in the setting of acute onset and successful RD surgery.
Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.
Yong-Kyu
YK
Kim
Se Joon
SJ
Woo
Kyu Hyung
KH
Park
Young Suk
YS
Yu
Hum
H
Chung
D000328:Adult; D001826:Body Fluids / Q000502:physiology*; D005122:Exudates and Transudates / Q000502:physiology*; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D020127:Recovery of Function; D012163:Retinal Detachment / Q000503:physiopathology / Q000601:surgery*; D012591:Scleral Buckling; D014792:Visual Acuity / Q000502:physiology*; D014821:Vitrectomy
D005466:Fluorocarbons; C042852:perflutren